Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 124,618 |
|
|||||
| News | - | ||||||
| Day High | 16.33 | Low High |
|||||
| Day Low | 15.98 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Innoviva Inc | INVA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.255 | 1.59% | 16.295 | 13:59:48 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 15.98 | 15.98 | 16.33 | 16.04 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,124 | 124,618 | US$ 16.19 | US$ 2,017,056 | - | 12.22 - 16.865 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 14:10:32 | 9 | US$ 16.295 | USD |
Innoviva Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.03B | 63.23M | - | 310.46M | 179.72M | 2.84 | 5.74 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Innoviva News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical INVA Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 15.40 | 16.40 | 15.32 | 15.81 | 365,127 | 0.895 | 5.81% |
| 1 Month | 15.66 | 16.52 | 15.155 | 15.85 | 500,384 | 0.635 | 4.05% |
| 3 Months | 14.71 | 16.52 | 14.325 | 15.18 | 607,263 | 1.59 | 10.77% |
| 6 Months | 14.71 | 16.865 | 14.2508 | 15.48 | 681,509 | 1.59 | 10.77% |
| 1 Year | 13.23 | 16.865 | 12.22 | 14.33 | 657,724 | 3.07 | 23.17% |
| 3 Years | 12.98 | 20.7056 | 10.64 | 14.89 | 745,811 | 3.32 | 25.54% |
| 5 Years | 13.91 | 20.7056 | 7.58 | 13.96 | 710,924 | 2.39 | 17.15% |
Innoviva Description
| Innoviva Inc develops biopharmaceutical drugs in the antibiotic, respiratory, and digestive realms. Theravance's respiratory compounds are in late-stage trials for asthma and chronic obstructive pulmonary disease. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others. The firm collaborates with and receives funding from GlaxoSmithKline. |
